Letter to the Editor

With interest we read the article by Simon et al. about 4 patients with complex-I deficiency due to mutations in the *NDUFAF5* gene \[[@bb0005]\]. The phenotype and the outcome of these 4 patients varied considerably \[[@bb0005]\]. We have the following comments and concerns.

The main shortcoming of this case series is that no prospective studies for multisystem involvement had been carried out. Multisystem disease in mitochondrial disorders (MIDs) may be subclinical or mild and thus frequently overlooked, why these patients need to be systematically investigated for multiorgan affection. Additionally, no comprehensible explanation for the marked phenotypic variability was provided.

MRI in patient-4 revealed DWI hyperintense serpiginous lesions \[[@bb0005]\]. To clarify if these lesions represent a cytotoxic or vasogenic edema it would be helpful to know the results of the ADC maps. Hypointensity of the ADC maps would suggest cytotoxic edema and thus ischemia, whereas hyperintense ADC maps would suggest vasogenic edema and thus a stroke-like lesion, which would require treatment with NO-precursors, antiepileptic drugs (AEDs), antioxidants, and steroids \[[@bb0010]\].

In patient-3 arterial hypertension was attributed to administration of ACTH ([Table 1](#t0005){ref-type="table"}) \[[@bb0005]\]. However, patient-1 had arterial hypertension in the absence of a plausible trigger. Since arterial hypertension has been repeatedly reported as a primary manifestation of mitochondrial disorders (MIDs) \[[@bb0015]\], it is conceivable that arterial hypertension in patient-1 as well as patient-3 was a primary phenotypic manifestation of the *NDUFAF5* mutation.Table 1Findings in the 4 reported patients.Table 1Patient1234EthnicityTaiwaneseTaiwaneseCaucasianAshkenaziAge10 m7 y4 m12 mSexFemaleFemaleMaleMaleOnset6 m27 m1 mBirthOnset manifestationDysphagiaStrabismRefluxDevelop. delayPhenotypeHead dropOligohydramnionIrritabilityTorticollisNystagmusPtosisInsomniaNystagmusBlepharospasmVomitingSeizuresHead bobbingVomitingOptic atrophyTruncal hypotoniaHypotoniaHypotoniaFatigueLimb spasticityDysmorphismWeight lossMuscle WeaknessCortical blindnessDysphagiaSIADHHeadacheDysphagiaVomitingHypertensionTremorContracturesSpasticityHypertensionSeizuresPruritusGI dysmotilityHyponatriemiaYesYesNoNoLactic acidosis serumYesNoYesYesLactic acidosis CSFndNoYesYesAmino acids serumndNormalAbnormalndAbnormal UOAsYesYesYesNoMRI lesionsThalamusMedullaThalamusThalamusMidbrainUpper cervical cordMidbrainDWICC dysgeneisMuscle biopsyndFat dropletsRRFndBiochemistryndNormalC-I defectndGeneNDUFAF5NDUFAF5NDUFAF5NDUFAF5Mutationsc.155A \> Cp.Met279Argc.327G \> Cc.327G \> Cc.836 T \> Gc.749G \> TTreatmentThiamineThiamineACTHBiotinCoenzyme-Q10Coenzyme-QHydralazinePantotheniacid[l]{.smallcaps}-carnitineRiboflavinAmlodipineThiaminePropranololL-carnitienEnalapril[l]{.smallcaps}-carintineHydrochlorothiazideLabetalolVigabatrinFundoplicationPropranololCaptoprilGabapentinLisinoprilEnalaprilOutcomeDeath at 25 mAlive at 19 yDeath at 6 mDeath at 17 m[^1]

Both Taiwanese patients had severe hyponatremia ([Table 1](#t0005){ref-type="table"}) \[[@bb0005]\]. We should be informed if this was due to primary or secondary hypoaldosteronism, or due to pituitary insufficiency, occasionally occurring as endocrine manifestations of a MID \[[@bb0020]\].

Overall, this case study could be more meaningful if clinical variability and MRI-findings in patient-3 would have been more extensively discussed and if all patients would have been systematically investigated for multisystem involvement.
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[^1]: SIADH: syndrome of inappropriate atidiuretic hormone secretion, CSF: cerebrospinal fluid, UOAs: urine oranic acids, CC: corpus callosum, GI: gastrointestinal, RRF: ragged-red fibers, ACTH: adreno-corticotropic hormone, nd: not done.
